Weight loss drug Wegovy to be listed on PBS
Wegovy will be heavily subsidised for Australians with severe obesity, who have also experienced a cardiovascular event, like…
Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical…
Novo Nordisk just pulled off something nobody saw coming
Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry…
GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds
This article first appeared on GuruFocus. Weight loss may be just one side effect of GLP-1 drugs. A…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National
Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks – Endpoints News
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsU.S.…
Ozempic Prices Lowered After Trump Deal
Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…
Why Weight-Loss Drug Prices Are Falling| Business News
President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…